Fouad Namouni - Oct 4, 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
PRESIDENT, R & D
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Oct 4, 2022
Transactions value $
-$234,002
Form type
4
Date filed
10/5/2022, 06:54 PM
Previous filing
Mar 8, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Sale -$234K -3.48K -6.18% $67.30 52.8K Oct 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.